Zobrazeno 1 - 3
of 3
pro vyhledávání: '"C. Serrrate"'
Autor:
Christian Pfister, Valentin Harter, Yves Allory, François Radvanyi, Stéphane Culine, G. Grawis, G. Pignot, A. Flechon, J.P. Fendler, C. Chevreau, M. Soulie, H. Mahammedi, L. Guy, B. Laguerre, G. Verhoest, A. Guillot, N. Mottet, F. Joly, A. Doerfler, S. Abadie-Lacourtoisie, A.R. Azzouzi, P. Mongiat, L. Geoffrois, P. Eschwege, F. Di Fiore, G. Roubaud, J.L. Hoepffner, P. Barthelemy, H. Lang, E. Voog, E. Mandron, J.M. Tourani, C. Serrrate, A. Colau, C. Saldana, A. de La Taille, T. Nguyen, F. Kleinclauss, Y. Loriot, J. Irani, J.C. Eymard, S. Larre, O. Huillard, M. Zerbib, F. Rolland, J. Rigaud, N. Houede, S. Droupy, G. Malouf, M. Roupret, M. El Demery, C. Legon, S. Vieillot, N. Letang, T. Lharidon, N. Gaschignard, W. Hilgers, J.L. Davin
Publikováno v:
Contemporary Clinical Trials Communications, Vol 17, Iss , Pp - (2020)
The main objective of the French GETUG/AFU V05 VESPER randomized phase III study was to assess the efficacy of dd-MVAC and GC in term of progression-free survival in patients for whom chemotherapy has been decided, before or after surgery.A total of
Externí odkaz:
https://doaj.org/article/f43ed578297242ffbca2d23538b428ab
Autor:
P. Eschwege, G. Verhoest, T. Nguyen, M. El Demery, G. Grawis, T. Lharidon, J.P. Fendler, C. Serrrate, H. Mahammedi, F. Di Fiore, N. Gaschignard, M. Zerbib, S. Droupy, C. Legon, N. Houédé, F. Kleinclauss, S. Vieillot, A. Colau, M. Soulié, François Radvanyi, G. Pignot, N. Letang, P. Barthelemy, Stéphane Culine, L. Guy, G. Malouf, P. Mongiat, J. Irani, A. Flechon, M. Roupret, L. Geoffrois, J.C. Eymard, J.M. Tourani, Valentin Harter, N. Mottet, O. Huillard, Y. Loriot, A. Doerfler, J. Rigaud, H. Lang, F. Rolland, Yves Allory, W. Hilgers, E. Voog, C. Chevreau, E. Mandron, S. Abadie-Lacourtoisie, A.R. Azzouzi, G. Roubaud, C. Saldana, S. Larre, J.L. Hoepffner, B. Laguerre, A. de la Taille, J.L. Davin, F. Joly, Christian Pfister, A. Guillot
Publikováno v:
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications, 2020, 17, pp.100536. ⟨10.1016/j.conctc.2020.100536⟩
Contemporary Clinical Trials Communications, Elsevier, 2020, 17, pp.100536. ⟨10.1016/j.conctc.2020.100536⟩
Contemporary Clinical Trials Communications, Vol 17, Iss, Pp-(2020)
Contemporary Clinical Trials Communications, 2020, 17, pp.100536. ⟨10.1016/j.conctc.2020.100536⟩
Contemporary Clinical Trials Communications, Elsevier, 2020, 17, pp.100536. ⟨10.1016/j.conctc.2020.100536⟩
Contemporary Clinical Trials Communications, Vol 17, Iss, Pp-(2020)
The main objective of the French GETUG/AFU V05 VESPER randomized phase III study was to assess the efficacy of dd-MVAC and GC in term of progression-free survival in patients for whom chemotherapy has been decided, before or after surgery.A total of
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.